NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

The scheme will co-ordinate work by the MHRA, NICE, SMC and NHSE&I to support and advise companies launching their medicines in the UK so that NHS patients have access to innovative new medicines sooner.

National Institute for Health and Care Excellence